Literature DB >> 2408733

Macrophage-histiocytes in Hodgkin's disease. The relation of peanut-agglutinin-binding macrophage-histiocytes to clinicopathologic presentation and course of disease.

H J Ree, M E Kadin.   

Abstract

The authors studied the occurrence of peanut agglutinin (PNA)-binding cells in paraffin-embedded specimens of 145 patients with Hodgkin's disease (HD). The staining reaction of lymphocytes was consistently negative. A positive staining reaction was observed in two types of cells: macrophage-histiocytes (M-H), and Reed-Sternberg (R-S) cells and their variants. Diffuse or globular cytoplasmic staining was found in M-H, which was easily distinguished from a unique "cell surface and cytoplasmic" staining pattern of R-S and related cells. Thus defined, M-H were numerous in lymphocyte depletion and mixed cellularity, less common in lymphocyte predominance, and least frequent in the nodular sclerosis type. Numerous M-H correlated with B-symptoms and a poor response to therapy. Among the asymptomatic patients with localized disease at presentation, the presence of large numbers of M-H was associated with a high incidence of relapse within 2 years of therapy. These findings suggest that the number of non-neoplastic M-H in HD may be an important determinant in the clinical presentation and course of disease. Peanut agglutinin staining may be useful for the detection of M-H in routine diagnosis and classification of HD, which has not been feasible by conventional methods.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2408733     DOI: 10.1002/1097-0142(19850715)56:2<333::aid-cncr2820560222>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Bauhinia purpurea--a new paraffin section marker for Reed-Sternberg cells of Hodgkin's disease. A comparison with Leu-M1 (CD15), LN2 (CD74), peanut agglutinin, and Ber-H2 (CD30).

Authors:  A B Sarker; T Akagi; H J Jeon; K Miyake; I Murakami; T Yoshino; K Takahashi; S Nose
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

2.  Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma.

Authors:  Beatriz Sánchez-Espiridión; Ana M Martin-Moreno; Carlos Montalbán; L Jeffrey Medeiros; Francisco Vega; Anas Younes; Miguel A Piris; Juan F Garcia
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

3.  Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.

Authors:  Peter Kamper; Knud Bendix; Stephen Hamilton-Dutoit; Bent Honoré; Jens R Nyengaard; Francesco d'Amore
Journal:  Haematologica       Date:  2010-11-11       Impact factor: 9.941

4.  Macrophages predict treatment outcome in Hodgkin's lymphoma.

Authors:  Christian Steidl; Pedro Farinha; Randy D Gascoyne
Journal:  Haematologica       Date:  2011-02       Impact factor: 9.941

Review 5.  Hodgkin's lymphoma therapy: past, present, and future.

Authors:  Bharti Rathore; Marshall E Kadin
Journal:  Expert Opin Pharmacother       Date:  2010-12       Impact factor: 3.889

6.  Morphological and immunohistochemical studies of Hodgkin's disease in the spleen.

Authors:  M Takeshita; S Falk; J Schwetje; H J Stutte
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

7.  Lectin histochemistry of human gliomas.

Authors:  X C Wang; N Kochi; E Tani; K Kaba; T Matsumoto; H Shindo
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

8.  Hodgkin's Lymphomas: A Tumor Recognized by Its Microenvironment.

Authors:  S Montes-Moreno
Journal:  Adv Hematol       Date:  2010-10-24

9.  Site-specific monoclonal antibodies against peanut agglutinin (PNA) from Arachis hypogaea. Immunohistochemical study of tissue-cultured cells and of 27 cases of Hodgkin's disease.

Authors:  D Burroni; M Cintorino; L Leoncini; P Tosi; C Ceccarini
Journal:  Am J Pathol       Date:  1988-05       Impact factor: 4.307

10.  Macrophages and dendritic cells as actors in the immune reaction of classical Hodgkin lymphoma.

Authors:  Christiane Silke Tudor; Heiko Bruns; Christoph Daniel; Luitpold Valentin Distel; Arndt Hartmann; Armin Gerbitz; Maike Julia Buettner
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.